Document is current
Any future updates will be listed below
-
Authors
Teipel, Stefan
Akmatov, Manas
Michalowsky, Bernhard
Riedel-Heller, Steffi
Bohlken, Jens
Holstiege, Jakob
-
Funding
Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 20 December 2024
First Online: 16 January 2025
Declarations
:
: The use of claims data for scientific research in Germany is regulated by the Code of Social Law (Sozialgesetzbuch, SGB V). Ethical approval and informed consent are not required for routinely collected pseudonymized data.
: Not applicable.
: ST was serving on advisory boards of Lilly, Eisai, and Biogen. He is member of the Independent Data Safety and Monitoring Board of the study ENVISION (Biogen). JH, JB, SRH, BM, and MA have nothing to disclose.
